0RU9

Gt Biopharma (0RU9)

Gt Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0RU9

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/09/12	20 : 30	PR Newswire (US)	GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial	LSE:0RU9	Gt Biopharma Inc
2019/09/12	20 : 30	PR Newswire (US)	GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial	LSE:0RU9	Gt Biopharma Inc
2019/06/13	20 : 30	PR Newswire (US)	GT Biopharma GTB-1550	LSE:0RU9	Gt Biopharma Inc
2019/06/13	20 : 30	PR Newswire (US)	GT Biopharma GTB-1550	LSE:0RU9	Gt Biopharma Inc
2019/05/29	20 : 30	PR Newswire (US)	GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago	LSE:0RU9	Gt Biopharma Inc
2019/05/29	20 : 30	PR Newswire (US)	GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago	LSE:0RU9	Gt Biopharma Inc
2019/03/26	20 : 30	PR Newswire (US)	GT Biopharma Announces Completion of Management Restructuring	LSE:0RU9	Gt Biopharma Inc
2018/08/30	21 : 00	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...	LSE:0RU9	Gt Biopharma Inc
2018/08/29	20 : 45	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...	LSE:0RU9	Gt Biopharma Inc
2018/08/24	21 : 00	PR Newswire (US)	GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance	LSE:0RU9	Gt Biopharma Inc
2018/08/14	21 : 00	PR Newswire (US)	GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference	LSE:0RU9	Gt Biopharma Inc
2018/07/25	21 : 00	PR Newswire (US)	GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/07/19	21 : 00	PR Newswire (US)	GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...	LSE:0RU9	Gt Biopharma Inc
2018/06/05	21 : 00	PR Newswire (US)	GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares	LSE:0RU9	Gt Biopharma Inc
2018/05/14	20 : 45	PR Newswire (US)	Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company	LSE:0RU9	Gt Biopharma Inc
2018/04/26	21 : 30	PR Newswire (US)	Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/04/24	22 : 15	PR Newswire (US)	Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/03/29	22 : 05	PR Newswire (US)	GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness	LSE:0RU9	Gt Biopharma Inc
2018/02/13	21 : 45	PR Newswire (US)	GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia	LSE:0RU9	Gt Biopharma Inc
2018/01/24	22 : 39	PR Newswire (US)	GT Biopharma, Inc. Issues Letter to Shareholders	LSE:0RU9	Gt Biopharma Inc
2017/12/19	00 : 27	PR Newswire (US)	GT Biopharma, Inc. Files Application for NASDAQ Capital Market Listing	LSE:0RU9	Gt Biopharma Inc